Tomas G. Neilan, MD, MPH, FACC

Professional Bio:

Dr. Neilan is an Associate Professor of Medicine at Harvard Medical School, the Director of the Cardio-oncology Program at Massachusetts General Hospital, the Co-Director Cardiovascular Imaging Research Program at Massachusetts General Hospital and the Associate Director of the MGH T32 Training Program in Cardiovascular Imaging. Dr. Neilan completed his MD at University College Dublin Medical School. He completed his clinical training in Internal Medicine and Cardiology at the Mater Hospital in Dublin and at Massachusetts General Hospital. He also competed advanced training in Echocardiography at Massachusetts General Hospital, a Cardiac MRI fellowship at the Brigham and Women’s Hospital and a master of public health degree at the Harvard School of Public Health. Dr. Neilan has been awarded the “de Gunzburg Family Endowed Scholar in Cardiology”, The Locke Award for excellence in medical education and elected as a Senior Fellow to the Oliver Wendell Holmes Society at Harvard Medical School. His career has had two major focuses: 1) Understanding how we can improve the cardiovascular care of patients with cancer and 2) The use of advanced imaging to better understand and characterize cardiovascular disease among persons living with HIV.

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bristol-Myers Squibb Company (SIGNIFICANT), Parexel(SIGNIFICANT), Intrinsic Imaging(SIGNIFICANT), AbbVie, Inc.(MODEST), Genentech, Inc(MODEST), Roche(MODEST), Amgen Inc.(SIGNIFICANT), Sanofi-Aventis(SIGNIFICANT), CRC Oncology(MODEST) RESEARCH/RESEARCH GRANTS: Astra Zeneca(NONE), Bristol Myers Squibb(SIGNIFICANT)

View Full Disclosure